FHTX
Price
$5.02
Change
+$0.04 (+0.80%)
Updated
Aug 8, 10:30 AM (EDT)
Capitalization
278.71M
95 days until earnings call
XNCR
Price
$7.19
Change
-$0.13 (-1.78%)
Updated
Aug 8, 12:55 PM (EDT)
Capitalization
522.08M
94 days until earnings call
Interact to see
Advertisement

FHTX vs XNCR

Header iconFHTX vs XNCR Comparison
Open Charts FHTX vs XNCRBanner chart's image
Foghorn Therapeutics
Price$5.02
Change+$0.04 (+0.80%)
Volume$100
Capitalization278.71M
Xencor
Price$7.19
Change-$0.13 (-1.78%)
Volume$923
Capitalization522.08M
FHTX vs XNCR Comparison Chart in %
Loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FHTX vs. XNCR commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (FHTX: $5.00 vs. XNCR: $7.32)
Brand notoriety: FHTX and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 90% vs. XNCR: 157%
Market capitalization -- FHTX: $278.71M vs. XNCR: $522.08M
FHTX [@Biotechnology] is valued at $278.71M. XNCR’s [@Biotechnology] market capitalization is $522.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • FHTX’s TA Score: 4 bullish, 5 bearish.
  • XNCR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than FHTX.

Price Growth

FHTX (@Biotechnology) experienced а -4.76% price change this week, while XNCR (@Biotechnology) price change was -12.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.22%. For the same industry, the average monthly price growth was +6.60%, and the average quarterly price growth was +12.79%.

Reported Earning Dates

FHTX is expected to report earnings on Nov 11, 2025.

XNCR is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+0.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($522M) has a higher market cap than FHTX($279M). FHTX YTD gains are higher at: 5.932 vs. XNCR (-68.146). FHTX has higher annual earnings (EBITDA): -91.89M vs. XNCR (-161.68M). XNCR has more cash in the bank: 470M vs. FHTX (221M). FHTX has less debt than XNCR: FHTX (34.9M) vs XNCR (67.8M). XNCR has higher revenues than FHTX: XNCR (127M) vs FHTX (23.5M).
FHTXXNCRFHTX / XNCR
Capitalization279M522M53%
EBITDA-91.89M-161.68M57%
Gain YTD5.932-68.146-9%
P/E RatioN/AN/A-
Revenue23.5M127M19%
Total Cash221M470M47%
Total Debt34.9M67.8M51%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FHTXXNCR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 17 days ago
86%
Bullish Trend 17 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
63%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEMFX35.25N/A
N/A
T. Rowe Price Instl Emerging Mkts Eq
OIGCX30.87N/A
N/A
Invesco Oppenheimer International Gr C
TFFCX70.21N/A
N/A
Touchstone Focused C
MDFSX7.79N/A
N/A
Manning & Napier Disciplined Value S
EEMGX9.26N/A
N/A
MFS Emerging Markets Equity Research R4

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with IPSC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
+2.04%
IPSC - FHTX
49%
Loosely correlated
-2.43%
ABOS - FHTX
48%
Loosely correlated
+4.41%
XNCR - FHTX
48%
Loosely correlated
-2.27%
IMNM - FHTX
47%
Loosely correlated
-5.64%
CRSP - FHTX
47%
Loosely correlated
-0.67%
More